← Leaderboards
Matthew A Rank
Mayo Clinic Arizona
$364,603
Attributed
$364,603
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $122.9K · FY2013–20$200K$150K$100K$50K$0
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$265,560 · 1
AHRQ$99,043 · 1
By mechanism
R21$265,560 · 1
R03$99,043 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Morbidity - Disease Rate”
- Marco Pahor · Wake Forest University Health Sciences$29,421,775
- A Benedict Cosimi · Massachusetts General Hospital$17,236,164
- Judith S. Currier · University Of California Los Angeles$11,229,603
- Andrea Jenay Ruff · Johns Hopkins University$10,896,035
- Lucile L Adams-Campbell · Howard University$10,384,616
- Michael K Ong · University Of California Los Angeles$9,898,332
Research focus
Morbidity - Disease RatePractice SettingPublic HealthAsthmaBaseHigh RiskPharmaceutical PreparationsPredictive ModelingData SetFutureAftercareFunctional DisorderAgonistBiologicalGuidelinesData WarehouseAffectDecision MakingBurden Of IllnessCase SeriesChronicAsthma InhalerAsthmatic PatientComputerized Medical Record
Grant awards (4)
Step down of asthma biologics in real-world practice settings$21,370
R21 · FY2020 · HL · contact PI
Step down of asthma biologics in real-world practice settings$121,287
R21 · FY2019 · HL · contact PI
Step down of asthma biologics in real-world practice settings$122,903
R21 · FY2018 · HL · contact PI
Bending the asthma cost curve: Is optimizing medication the answer?$99,043
R03 · FY2013 · HS · contact PI